|
RWDD4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.94040003456786E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3860999998071E-07 |
| Normal-vs-Stage2 |
4.542400E-01 |
| Normal-vs-Stage3 |
2.1581999999909E-05 |
| Normal-vs-Stage4 |
1.82660553349479E-11 |
| Stage1-vs-Stage2 |
1.933820E-01 |
| Stage1-vs-Stage3 |
2.096400E-01 |
| Stage1-vs-Stage4 |
2.835400E-03 |
| Stage2-vs-Stage3 |
5.243700E-02 |
| Stage2-vs-Stage4 |
1.319560E-02 |
| Stage3-vs-Stage4 |
4.684000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27110000303077E-09 |
| Normal-vs-AfricanAmerican |
6.371500E-02 |
| Normal-vs-Asian |
2.499200E-01 |
| Caucasian-vs-AfricanAmerican |
2.486400E-01 |
| Caucasian-vs-Asian |
7.598000E-01 |
| AfricanAmerican-vs-Asian |
8.936600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29950003483026E-09 |
| Normal-vs-Female |
4.47639999999749E-05 |
| Male-vs-Female |
1.679760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.240830E-03 |
| Normal-vs-Age(41-60Yrs) |
5.0434999998572E-07 |
| Normal-vs-Age(61-80Yrs) |
5.34779999949997E-07 |
| Normal-vs-Age(81-100Yrs) |
2.628100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.276600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.276000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.789000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.291000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.568600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.723800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.330600E-01 |
| Normal-vs-Grade 2 |
1.402430E-03 |
| Normal-vs-Grade 3 |
7.65021379578457E-12 |
| Normal-vs-Grade 4 |
2.00628402780012E-12 |
| Grade 1-vs-Grade 2 |
5.801200E-01 |
| Grade 1-vs-Grade 3 |
2.893000E-01 |
| Grade 1-vs-Grade 4 |
1.523050E-01 |
| Grade 2-vs-Grade 3 |
9.501900E-03 |
| Grade 2-vs-Grade 4 |
1.368310E-04 |
| Grade 3-vs-Grade 4 |
7.383600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.575140E-04 |
| Normal-vs-ccB subtype |
3.70950000000425E-05 |
| ccA subtype-vs-ccB subtype |
1.981410E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.556990E-04 |
| Normal-vs-N1 |
5.019300E-03 |
| N0-vs-N1 |
2.242800E-01 |
|
|
